首页 | 本学科首页   官方微博 | 高级检索  
     


Twelve Months of Routine HIV Screening in 6 Emergency Departments in the Paris Area: Results from the ANRS URDEP Study
Authors:Enrique Casalino  Bruno Bernot  Olivier Bouchaud  Chakib Alloui  Christophe Choquet  Elisabeth Bouvet  Florence Damond  Sandra Firmin  Aurore Delobelle  Beatrice Ename Nkoumazok  Guillaume Der Sahakian  Jean-Paul Viard  Olivier Zak Dit Zbar  Elisabeth Aslangul  Anne Krivine  Julie Zundel  Jade Ghosn  Patrice Nordmann  Yann-Erick Claessens  Tassadit Tahi  Bruno Riou  Agnès Gautheret-Dejean  Christine Katlama  Pierre Hausfater  Fran?oise Brun-Vézinet  Dominique Costagliola
Abstract:

Objective

In October 2009 the French National Authority for Health recommended that HIV testing be proposed at least once to all persons aged 15 to 70 years in all healthcare settings. We examined whether routine HIV screening with a rapid test in emergency departments (EDs) was feasible without dedicated staff, and whether newly diagnosed persons could be linked to care.

Methods

This one-year study started in December 2009 in 6 EDs in the Paris area, using the INSTI™ test. Eligible individuals were persons 18 to 70 years old who did not present for a vital emergency, for blood or sexual HIV exposure, or for HIV screening. Written informed consent was required.

Results

Among 183 957 eligible persons, 11 401 were offered HIV testing (6.2%), of whom 7936 accepted (69.6%) and 7215 (90.9%) were tested (overall screening rate 3.9%); 1857 non eligible persons were also tested. Fifty-five new diagnoses of HIV infection were confirmed by Western blot (0.61% (95% CI 0.46–0.79). There was one false-positive rapid test result. Among the newly diagnosed persons, 48 (87%) were linked to care, of whom 36 were not lost to follow-up at month 6 (75%); median CD4 cell count was 241/mm3 (IQR: 52–423/mm3).

Conclusions

Screening rates were similar to those reported in opt-in studies with no dedicated staff. The rate of new diagnoses was similar to that observed in free anonymous test centres in the Paris area, and well above the prevalence (0.1%) at which testing has been shown to be cost-effective.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号